Announce Date | 08/05/2025 |
EPS Normalized Actual | $4.72 (Miss by $-0.17) |
EPS GAAP Actual | $4.72 (Miss by $-0.17) |
Revenue Actual | $16.569B |
Revenue Surprise | Beat by $16569M |
Announce Date | 10/01/2025 (Pre-Market) |
EPS Normalized Estimate | $5.56044 |
EPS GAAP Estimate | $5.56044 |
Revenue Estimate | $17.173001252B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 27.3831 | 18.27 | 25.48335 | 28.82579 | 4 |
Dec 2027 | 24.32896 | 20.57 | 22.11377 | 25.87139 | 7 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 4.6391 | -0.97317 | 16.569B | -0.72% | -1113.44M |
FQ1 2025 (Mar 2025) | 0 | 0 | 14.249B | -10.88% | 14249M |
FQ4 2024 (Dec 2024) | 5.76 | 5.76 | 16.215B | 100% | 16215M |
FQ3 2024 (Sep 2024) | 5.09 | 5.09 | 16.106B | -4.37% | 16106M |
FQ2 2024 (Jun 2024) | 5.5 | 5.5 | 16.689B | -3.77% | 16689M |
FQ1 2024 (Mar 2024) | 0 | 0 | 15.799B | -0.4% | 15799M |
FQ4 2023 (Dec 2023) | 0 | 0 | 0B | -INF% | 0M |
FQ3 2023 (Sep 2023) | 0 | 0 | 16.81B | 10.8% | 16810M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
5.56044
Consensus Revenue Estimates
17.173001252B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 5.72807 | -- | 5.29054 | 6.09412 | 5 |
FQ3 2027 (Sep 2027) | 5.79979 | -- | 5.35678 | 6.17042 | 5 |
FQ2 2027 (Jun 2027) | 6.16344 | -- | 5.69266 | 6.55731 | 5 |
FQ1 2027 (Mar 2027) | 5.5585 | -- | 5.13392 | 5.91371 | 5 |
FQ4 2026 (Oct 2026) | 5.89652 | -- | 5.6785 | 6.14086 | 6 |
FQ3 2026 (Jul 2026) | 6.10473 | -- | 5.87902 | 6.3577 | 11 |
FQ2 2026 (Jun 2026) | 5.93636 | 21.85 | 5.62983 | 6.24141 | 9 |
FQ1 2026 (Mar 2026) | 5.42072 | -- | 5.14081 | 5.69927 | 9 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 17.63B | -- | 16.59B | 18.5B | 5 |
FQ3 2027 (Sep 2027) | 17.06B | -- | 16.06B | 17.9B | 4 |
FQ2 2027 (Jun 2027) | 17.43B | -- | 16.4B | 18.29B | 5 |
FQ1 2027 (Mar 2027) | 16.27B | -- | 15.32B | 17.07B | 4 |
FQ4 2026 (Oct 2026) | 17.95B | -- | 17.44B | 18.52B | 8 |
FQ3 2026 (Jul 2026) | 18.42B | -- | 17.9B | 19.01B | 5 |
FQ2 2026 (Jun 2026) | 18.32B | 9.56 | 17.59B | 19.05B | 6 |
FQ1 2026 (Mar 2026) | 16.95B | 15.95 | 16.28B | 17.62B | 12 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
1
EPS # of in-lines
4
Revenue # of Beats
6
Revenue # of Misses
1
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 5.61227 | 4.6391 | -0.97317 | -20.98% |
FQ1 2025 (Mar 2025) | 0 | 0 | NAN% | |
FQ4 2024 (Dec 2024) | 5.76 | 5.76 | 100% | |
FQ3 2024 (Sep 2024) | 5.09 | 5.09 | 100% | |
FQ2 2024 (Jun 2024) | 5.5 | 5.5 | 100% | |
FQ1 2024 (Mar 2024) | 0 | 0 | NAN% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | 0 | 0 | NAN% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $17.68B | $16.57B | $-1113.44M | -6.72% |
FQ1 2025 (Mar 2025) | $0B | $14.25B | $14249M | 100% |
FQ4 2024 (Dec 2024) | $0B | $16.22B | $16215M | 100% |
FQ3 2024 (Sep 2024) | $0B | $16.11B | $16106M | 100% |
FQ2 2024 (Jun 2024) | $0B | $16.69B | $16689M | 100% |
FQ1 2024 (Mar 2024) | $0B | $15.8B | $15799M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0B | $0M | NAN% |
FQ3 2023 (Sep 2023) | $0B | $16.81B | $16810M | 100% |